City of Brampton
Brampton has a strong competitive position because of its diverse and resilient economic base. It has transformed its economic development approach to target high growth business sectors. Our location in the middle of the Innovation Super Corridor, and new strategic investments, like a university, will have a significant and positive impact on the regional labour force and long-term job growth in Brampton.
According to Statistics Canada, Brampton placed 7th in the country for total construction value in 2016, generating $2 billion in investment. With high growth expected to continue until 2041, the City of Brampton is in a strong position to attract investment and will remain among the countrys most active markets in the coming decades.
Innovative Medicines Canada
Innovative Medicines Canada represents Canada’s innovative pharmaceutical industry. We help our members discover, develop, and deliver innovative medicines and vaccines. Our membership consists of more than 50 companies, from established organizations to fledgling startups, all of whom are revolutionizing healthcare through the discovery and development of new medicines and vaccines. Guided by a strict Code of Ethical Practices, we work with governments, insurance companies, healthcare professionals and stakeholders to advance the field and enhance the wellbeing of Canadians. We are committed to being valued partners in Canada’s healthcare system. We aim to achieve these goals by forming effective alliances and supporting policies, improving Canada’s regulatory environment, widen access to innovative medicines and protect intellectual property. We believe in ensuring that Canadians have access to the innovative treatments they need and that our activities are a fundamental part of safeguarding our healthcare system for future generations. Our work allows our members to focus on what matters: delivering better healthcare solutions to Canadians.
Sanofi Pasteur, the vaccines division of Sanofi, is the largest company in the world devoted entirely to human vaccines. Our driving goal is to protect people from infectious diseases by creating safe and effective vaccines. Our company offers the broadest range of vaccines in the world, providing protection against 20 bacterial and viral diseases. We distribute more than 1.6 billion doses of vaccine each year, making it possible to vaccinate more than 500 million people across the globe.
Scientus Pharma is an R&D biopharmaceutical company established in Toronto, Canada to conduct research and product development for extracts and formulations related to medical cannabinoids and derivatives. We are developing proprietary technologies and own know-how related to the chemistry and pharmacology of cannabinoids and potentially how they integrate with various medical devices and drug delivery technologies. The companys founders have a wealth of experience in the life sciences industry and access to laboratories at some of the top research institutions in Canada.
Horizon Therapeutics Canada
Horizon Therapeutics Canada is a wholly owned subsidiary of Horizon Pharma plc, a biopharmaceutical company focused on improving patients’ lives by developing and commercializing differentiated and accessible medicines that address unmet medical needs in the fields of rare diseases, rheumatology and primary care. Founded in 2008 as a small start-up, Horizon has evolved in less than a decade into a global biopharmaceutical company active in several important therapeutic fields.
Taiho Pharma Canada Inc.
Taiho Pharma Canada, Inc., a Canadian subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), is located in Oakville, Ontario and managed by Taiho Oncology based in Princeton, New Jersey. Taiho Pharma’s mission in Canada is to lead oncology innovation, drive research and transform the lives of Canadians living with cancer. Taiho Oncology has established world class clinical development and commercial organizations that work urgently to develop and market innovative cancer treatments. Taiho Oncology Inc. has an oral oncology pipeline consisting of both novel anti-metabolic agents and selectively targeted agents. Advanced technology, dedicated researchers, and state of the art facilities are helping Taiho define the way the world treats cancer. It’s our work; it’s our passion; it’s our legacy.
BDO Canada has spent more than 90 years providing assurance, accounting, tax, and advisory services to a broad range of clients across the country. And as a member firm of the international BDO network, we leverage access to resources and advisors in more than 150 countries around the world.
Founded in 1921, we have grown from a single office in Winnipeg to more than 3,000 partners and professionals in over 100 offices across Canada. Yet our strengths remain firmly rooted in the communities we serve.
At BDO, we aim to create a collaborative working environment that makes it possible for our professionals and clients to achieve their goals. We always begin at the local, individual level, delivering highly personalized guidance, industry-specific knowledge, and unparalleled service to exceed the expectations of every client – public or private, big or small. And as our team and our clients’ needs expand globally, we draw on our resources around the world.
Founded in 2005, Bond Consulting Group offers the most sophisticated and comprehensive SR&ED Solution in Canada. We are proud of our very high success rate, almost everything we’ve prepared over the years has been accepted, the vast majority accepted as filed with no requests from CRA. We have presided over 1200+ successful SR&ED claims. Bond Consulting Group and our team of scientists and engineers are dedicated to ensuring the success and approval of the SR&ED claims of our clients. There is no financial risk. If you do not receive a refund, then our services cost you nothing. Bond Consulting Group is conveniently located in Toronto, and we serve clients across Canada. With a team of scientists, technologists and engineers on staff, Bond is clearly focused and specialized in the SR&ED program. We are careful to get your complete strategy right when accessing government funding on different levels.
Ernst & Young LLP
At EY, we are committed to building a better working world — with increased trust and confidence in business, sustainable growth, development of talent in all its forms, and greater collaboration. We want to build a better working world through our own actions and by engaging with like-minded organizations and individuals. This is our purpose — and why we exist as an organization. Running through our organization is a strong sense of obligation to serve a number of different stakeholders who count on us to deliver quality and excellence in everything we do. We want to use our global reach and scale to convene the conversation about the challenges facing economies and the capital markets. When business works better, the world works better. Learn more about our commitment to building a better working world.
Numerous objective rankings from around the world name Richmond Hill as a top Canadian business destination. Richmond Hill has an enviable pool of immensely talented, well educated people, a diverse and resilient local economy, and a business base known for perseverance, innovation and entrepreneurial spirit. With exceptional transportation links, the most educated workforce in Canada, an economic development team eager to support you and a diverse and welcoming community, Richmond Hill is the smart place for business.